Alan Bäckerholm

4PUBLICATIONS
30CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersBiomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 23, 2025
Disruption of ATR Signaling by Epstein-Barr Virus Latent Membrane Protein 1 Sensitizes Nasopharyngeal Carcinoma Cells to Cisplatin.

Gabriella Zarkovic, Phillip Ziegler, Jennifer Hye-Rim Lee

|Nov 18, 2024
Mechanistic basis of atypical TERT promoter mutations.

Kerryn Elliott, Vinod Kumar Singh, Alan Bäckerholm

|Sep 27, 2022
Serologic Profiling Using an Epstein-Barr Virus Mammalian Expression Library Identifies EBNA1 IgA as a Prediagnostic Marker for Nasopharyngeal Carcinoma.

Sarita Paudel, Benjamin E Warner, Renwei Wang

|Apr 29, 2021
A primary nasopharyngeal three-dimensional air-liquid interface cell culture model of the pseudostratified epithelium reveals differential donor- and cell type-specific susceptibility to Epstein-Barr virus infection.

Phillip Ziegler, Yarong Tian, Yulong Bai

Pageof 1

Frequent Collaborators

3 joint publications

Kathy Ho Yen Shair

2 joint publications

Phillip Ziegler

2 joint publications

Alex S Reznik

1 joint publications

Yulong Bai